Cystine Transport and Cisplatin Resistance in Ovarian Cancer Cells
Author Information
Author(s): Okuno S, Sato H, Kuriyama-Matsumura K, Tamba M, Wang H, Sohda S, Hamada H, Yoshikawa H, Kondo T, Bannai S
Primary Institution: University of Tsukuba
Hypothesis
The study investigates the role of cystine transport in regulating intracellular glutathione levels and its impact on cisplatin resistance in human ovarian cancer cell lines.
Conclusion
The study found that cystine transport activity is significantly higher in cisplatin-resistant ovarian cancer cells, contributing to elevated glutathione levels and drug resistance.
Supporting Evidence
- Cisplatin-resistant cells showed a 4.5-fold increase in cystine uptake compared to sensitive cells.
- Intracellular glutathione levels were significantly higher in resistant cells.
- System xc− activity was transcriptionally activated in CDDP-resistant cells.
Takeaway
This study shows that cancer cells that resist a common drug called cisplatin can take in more cystine, which helps them survive by making a protective substance called glutathione.
Methodology
The study involved culturing human ovarian cancer cell lines, measuring cystine uptake, and assessing intracellular glutathione levels and drug sensitivity.
Limitations
The study primarily focuses on in vitro cell lines, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website